Originally developed for the management of T2DM, GLP-1 RAs have revolutionized treatment paradigms in cardiometabolic medicine, demonstrating substantial benefits in weight reduction, glycemic control, and CV outcomes [41,42]. Here, GCG is linked to type 2 diabetes mellitus.